Company Description
Omrix Biopharmaceuticals helps keep the operating room from becoming a bloody mess. The company develops biosealants derived from human plasma to...
Key Omrix Financials
| Company Type | Public - NASDAQ (GM): OMRI Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $61.7 |
| Employees | -- |
More Omrix Financials (8 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Omrix's competition across multiple industries
Top Omrix Competitors
Sponsored Links
The Business DirectoryOmrix Executives
| Title | Name & Bio | Contact |
|---|---|---|
| CEO and Director | Robert Taub | Network | E-mail |
| President and COO | Nissim Mashiach | Network | E-mail |
| EVP | V. Marc Droppert | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Omrix News
- FirstAlert: 4-4:30 P.M. Investrend / Bestcalls [InvesTrend] (05 Nov 2008 00:01:00 EST)
- Omrix Biopharmaceuticals, Inc. (OMRI) Corporate Event Announcement Notice [Wall Street Horizon] (03 Nov 2008 21:06:00 EST)
- BioWorld Today October 27, 2008 [BioWorld Today] (27 Oct 2008 00:01:00 EDT)
Sponsored Opportunity







